WHO WE ARE

Will be a major player in the healthcare sector, committed to manufacturing and distributing high quality pharmaceutical products, to improve human health and well-being.
Read more...

CONTACT INFO
  • Address: Zone 5A Industrial Area,No. 64,
    10th of Ramadan, Egypt
  • Phone: (20554) 410 901/902/903/904/905
  • Email: info@wnb-eg.com

Schisolazine Details

  • Olanzapine
  • Name of medicinal product: Schisolazine 5mg, 10mg oral dispersible tablets.
  • Qualitative and Quantitative Composition:
    Schisolazine 5mg: Each oral dispersible tablet contains Olanzapine 5mg.
    Schisolazine 10mg: Each oral dispersible tablet contains Olanzapine 10mg.
  • Pharmaceutical Firm: Schisolazine 5mg, 10mg oral dispersible tablets.
  • Therapeutic indications:
    Olanzapine is indicated for the treatment of schizophrenia.
    Olanzapine is effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response.
    Olanzapine is indicated for the treatment of moderate to severe manic episode.
    In patients whose manic episode has responded to Olanzapine treatment, Olanzapine is indicated for the prevention of recurrence in patients with bipolar disorder.

Contact us for Inquiry

Thank You! Your message successfully sent!
[SMTP] Error! Internal server error!
Sorry! You need to complete all mandatory (*) fields!